Loss of Prom1 impairs autophagy and promotes epithelial-mesenchymal transition in mouse retinal pigment epithelial

Sujoy Bhattacharya1, Jinggang Yin1, Weihong Huo1

  • 1Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

PubMed

Insights

Prominin-1 (Prom1) gene mutations impair retinal pigment epithelial (RPE) cell health and autophagy. Loss of Prom1 function in RPE cells drives cellular changes mimicking macular degeneration, suggesting Prom1 as a therapeutic target.

Area of Science:

  • Cell Biology
  • Ophthalmology
  • Genetics

Background:

  • Mutations in the Prominin-1 (Prom1) gene are linked to photoreceptor dysfunction and macular dystrophies.
  • Prominin-1 (Prom1) regulates human retinal pigment epithelial (RPE) homeostasis via autophagy, but its role in RPE cell-autonomy versus photoreceptor degeneration is unclear.

Purpose of the Study:

  • To investigate the role of Prominin-1 (Prom1) in mouse RPE (mRPE) autophagy and phagocytosis.
  • To determine if Prom1 deficiency causes cell-autonomous defects in mRPE.

Main Methods:

  • Generated Prominin-1 knockout (Prom1-KO) mRPE cells.
  • Assessed autophagy flux, mTORC1, TFEB, and Cathepsin-D activities.
  • Evaluated photoreceptor outer segment clearance by mRPE.
  • Analyzed expression of epithelial-mesenchymal transition (EMT) markers (ZO-1, E-cadherin, Vimentin, SNAI1, ZEB1).

Main Results:

  • Prom1-KO mRPE cells exhibited decreased autophagy flux, activated mTORC1, and reduced TFEB and Cathepsin-D activities.
  • Prom1 deficiency impaired the clearance of photoreceptor outer segments in mRPE cells.
  • Prom1-KO mRPE cells showed decreased ZO-1 and E-cadherin, with increased Vimentin, SNAI1, and ZEB1, indicating EMT induction.

Conclusions:

  • Prominin-1 (Prom1) is essential for mRPE cell-autonomous homeostasis through the Prom1-mTORC1-TFEB signaling pathway.
  • Prom1 deficiency in mRPE cells recapitulates key defects seen in atrophic age-related macular degeneration.
  • Targeting Prominin-1 (Prom1) presents a potential therapeutic strategy for retinal degenerative diseases.